Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two ...

Primary care physicians (PCPs) play a key role in treating young patients as they progress through the "atopic march" from ...

Advancing atopic dermatitis disease management Almirall ... Patient preference over other topicals, perception of cream usability, treatment adherence and satisfaction among patients with ...

Advancing atopic dermatitis disease management ... perception of cream usability, treatment adherence and satisfaction among patients with mild-to-moderate scalp psoriasis using calcipotriene ...

The late-breaker analysis included patients who had AD involvement on the face, scalp ... at nine months of treatment with Adtralza. 1 “Atopic dermatitis often affects multiple regions of ...

Later on in the day, confirmation finally came in – Zoryve had been approved as a new, once-daily treatment for mild to moderate atopic ... dermatitis that mainly affects the scalp.

Black people in the US are not only more likely than other folks to get eczema in childhood, but may have harder-to-treat or ...

I have checked for lice and found none, and even did a treatment ... Common scalp disorders in children include tinea capitis, seborrheic dermatitis, and atopic dermatitis that often cause scaly ...

“Scalp symptoms can be especially ... and roflumilast cream 0.15% for the topical treatment of mild to moderate atopic dermatitis.

May occur as a result of atopic and/or contact dermatitis. Arms, legs, back of the neck, backs of the hand, bottoms of the feet, scalp ... Eczema treatments that are scented or that contain ...